RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
(Other OTC:RTGN),(OTC US:RTGN), APOLLO BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) — RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, today announced that a recent largeâ€'scale Australian retinal mapping study, which used artificial intelligence to analyze approximately 50,000 retinal scans, reported that specific patterns of retinal thinning […]